Studie AIO-PAK-0114 ALPACA

AIO-PAK-0114 ALPACA

Induction treatment with nab-paclitaxel/gemcitabine for first-line treatment of metastatic pancreatic cancer followed by either alternating application of gemcitabine monotherapy and nab-paclitaxel/gemcitabine or continuing application of nab-paclitaxel/gemcitabine: A randomized phase II study

2. Med 2. Med Ismaninger Str. 22 81675 München Germany

II

Rekrutierung beendet

Unbekannt / Unbekannt

1

Chemo - Therapieart: palliativ